Peripheral Nerve Sheath Cancer
Malignant Peripheral Nerve Sheath Tumor
Female, 41 years
Patient Internal ID: 75735747
ICD-10 code
C47.0 Malignant Neoplasm: Peripheral Nerves of Head, Face, and Neck
Diagnosis (Incl. Metastases/Stage) and Year
December 2019
Malignant Peripheral Nerve Sheath Tumor pT3 N0M0, LVI (1), Ki67 – 30%. G3, No Lymph Node Metastases.
Previous Treatment
Surgery, Radiation Therapy.
Prognosis and Survival Expectation
The pooled data of 22 studies suggests that Malignant Peripheral Nerve Sheath Tumor 5-year overall survival rate was around 49%.
Treatment Provided
Autologous DCV (8 doses) and CIK (4 doses) over a period of 11 months. Additionally, the patient received Xenogeneic Preventive and Therapeutic Anti-Cancer Vaccine (PTAC) (10 vaccines) as well as Umbilical Cord Blood Derived NK cells (4 doses).
Patient Survival/Condition and Year
Date of Review: 01/11/2023
The patient has survived for 47 months so far, has no signs of disease and has regular check-ups with his oncologist. It can be concluded that the addition of Immunotherapy, alongside Surgery and Radiation Therapy, caused noticeable disease regression and stabilisation.
